Supporting people in hospitals across South Australia through vital health and medical research and improved patient care.
Meet our passionate and dedicated team.
Meet our Board and Governance team.
THRF adopts extremely high transparency standards when reporting our financials.
Supports research into the detection, management & treatment of breast cancer.
Funding research into prostate cancer prevention, detection & treatment.
Improving heart health through advances in knowledge & research to beat heart disease.
Our aim is to reduce & eliminate the high incidence of chronic kidney disease and diabetes.
Supports health and wellbeing research & programs for veterans, emergency service personnel and their families.
Driving collaboration, innovation & research to develop best-practice arts, design & health programs.
Supporting world-class stroke research to improve prevention, diagnosis & acute treatment to cure stroke.
Providing donor stool to treat patients with bowel conditions and foster research into faecal transplant as a treatment.
Do you want to join our team? Check out current career opportunities here.
View some of the commonly asked questions about our organisation.
We are so grateful to those who donate their time and skills to support life-changing medical research. Find out more…
Get in touch with us here.
Applications have now closed. All applicants will be advised of the outcome for this grant round in January 2017.
The Hospital Research Foundation (THRF) is proud to announce expressions of interest are now open for our inaugural grant round at the Royal Adelaide Hospital.
Two $250,000 Translational Grants that are ready to commence immediately are available to researchers and clinicians affiliated with the Royal Adelaide Hospital (RAH). Applications will close at 12.00 PM on the 15th December 2017 and short-listed applicants may be required to present more information to THRF’s independent review committee.
THRF has been supporting The Queen Elizabeth Hospital and the Basil Hetzel Institute for Translational Health Research for over 50 years and is now proud to extend its support more broadly across South Australia to include the Royal Adelaide Hospital and Centre for Cancer Biology. Our initial support included $1.6million in funding to support the RAH’s own Clinical Trials Centre and $1.1million for world-class cancer research at the Centre for Cancer Biology.
We have also been pleased to support renal research at the RAH, with $1.2million in grants over the past few years and the establishment of our affiliate brand, Kidney, Transplant and Diabetes Research Australia. This includes a recent announcement of $330,000 in funding to ensure six more pancreatic islet auto-transplants can take place at the RAH, saving the lives of people living with severe and hereditary pancreatitis. THRF also proudly supports crucial stroke research at the RAH with the upcoming launch of Cure for Stroke Australia. Both of these affiliate brands will operate out of the RAH.
In October 2017, we opened our own philanthropic hub in the Royal Adelaide Hospital and you can find us on Level 3 (Ground Floor) just opposite the food court. Come and see us to find out more about THRF, its affiliate brands and how we’re committed to helping you save lives and improve care in your hospital!
The Panel will provide absolute scores for each application to THRF. An example of a score would be the following:
All applications are to be submitted electronically no later than 12.00 PM on December 15th 2017 via our website or by completing the RAH Translational Grant – EOI Application and emailing to: email@example.com.
Applications must be endorsed by Prof Beltrame by the very latest at 6.00 AM on the December 15th 2017 to ensure they are signed off by the midday deadline. Applications should preferably be submitted earlier in the week since any questions that need to be addressed will have limited time before the close of applications.
If you are applying via our website, the application will be sent to Prof Beltrame automatically. If you are applying via email, please forward the application to Prof Beltrame (firstname.lastname@example.org).
All queries should be directed to Paul Flynn, THRF CEO at 8244 1100 or email@example.com.
You can download Guide to Applicants.